TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents

Moret, L.; Anthoine, Emmanuelle; Aubert-Wastiaux, Hélène; Rhun, Anne Le; Leux, Christophe; Mazereeuw‐Hautier, J.; Stalder, J.‐F.; Barbarot, S.

doi:10.1371/journal.pone.0076493

Cited by 77 publications

(97 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Atopic dermatitis was not the leading diagnosis of patients with TCC, and non-adherence was not associated with a specific diagnosis. Hence, the prevalence of TCC and consecutive non-adherence in our population with various diagnoses was comparable to that reported in atopic dermatitis [1,2,3,4,5,6,7,8,9,10,11]. To our knowledge, only one study addressed TCC in dermatoses other than atopic dermatitis [6].…”

Section: Discussionsupporting

confidence: 80%

“…TCC are an important issue in dermatological patients as TCS are a mainstay of treatment for various skin diseases. TCC may lead to non-adherence and poor disease control, resulting in serious long-term consequences, more hospitalisations, and increased health care costs [1,2,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]. However, study data on TCC are scarce and largely limited to patients with atopic dermatitis or their caregivers.…”

Section: Introductionmentioning

confidence: 99%

“…However, study data on TCC are scarce and largely limited to patients with atopic dermatitis or their caregivers. The prevalence of TCC in that context is 38-100% [1,2,3,4,5,6,7,8,9,10,11], resulting in 36-58% non-adherence to TCS [3,5]. Female gender of the child, paternal history of atopic dermatitis, and frequent change of clinics were described as predictive factors of TCC [4].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Müller

Tomaschett²,

Euler³

et al. 2016

Dermatology

View full text Add to dashboard Cite

Background/Aims: Topical corticosteroid concerns (TCC) are an important issue in patients with atopic dermatitis, leading to non-adherence with poor disease control and increased health care costs. However, neither the prevalence of TCC in a more comprehensible dermatological population nor the impact of patient information on topical corticosteroids given by clinicians is known. Therefore, we assessed the prevalence, characteristics, and sources of TCC in a dermatological population and the impact of written and oral patient information on TCC. Methods: A total of 643 outpatients with various skin diseases answered a 12-item questionnaire while waiting for the doctor's visit. Patients with TCC quantified their concerns on a discrete visual analogue scale before and after patient information, which consisted of written and oral information about topical corticosteroids (TCS) given by dermatologists. Results: The prevalence of TCC was 41.5%, and that of TCC-related non-adherence was 28.3%. TCC was positively associated with age <60 years, female gender, use of complementary and alternative medicine (CAM) and non-physician health care profession. The leading concerns were skin atrophy, systemic effects, and impairment of the immune system. The most frequent sources of TCC were negative reports by media, family, or friends. Both written and oral patient information significantly reduced TCC. The number needed to benefit from patient information was approximately 2. Non-responders were more often female, TCS-inexperienced, and users of CAM with an intermediate level of education. Conclusions: TCC are highly prevalent in dermatological patients. Patient information may lower TCC in almost every second patient.

show abstract

Section: Discussionsupporting

confidence: 80%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Müller

Tomaschett²,

Euler³

et al. 2016

Dermatology

View full text Add to dashboard Cite

show abstract

“…The six items concerning worries add up to a sum score for worries; the other six items, concerning beliefs, add up to a sum score for beliefs. These two scores together add up to the final score, ranging from zero to 36, expressed as a percentage . For this study, the questionnaire was translated into Dutch.…”

Section: Methodsmentioning

confidence: 99%

“…We used the Topicop questionnaire, consisting of questions addressing the worries and beliefs regarding topical corticosteroids to assess topical corticophobia among parents of atopic dermatitis patients and professionals . Several studies indicate that this questionnaire is applicable for patients and parents in different settings and can be used internationally.…”

Section: Introductionmentioning

confidence: 99%

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Bos

Antonescu

Osinga

et al. 2018

Pediatric Dermatology

View full text Add to dashboard Cite

Background Adherence to topical corticosteroids is low among atopic dermatitis patients and their parents. This can lead to treatment failure and decreased quality of life. Objective To assess and compare the worries and beliefs concerning topical corticosteroids among parents of children with atopic dermatitis, involved health care professionals, and between different professionals. Also, we identify factors associated with corticosteroid phobia (corticophobia) in professionals. Methods Parents and health care professionals were invited to complete a questionnaire about corticophobia (Topicop). Higher questionnaire scores, expressed as a percentage, indicate more severe corticophobia. Professionals were asked to answer the questions as though they were using topical corticosteroids on their own child. Results The scores for 29 parents and 31 public health care nurses were equal: 44%. The score for 51 general practitioners was 39%. The score for 33 public health care physicians and of 47 pediatricians was 31%. The differences between parents and these professionals were statistically significantly different (P = 0.001). Type of profession and having a child with atopic dermatitis were significantly associated factors for the score. Conclusion Corticophobia is present among parents of children with atopic dermatitis and among health care professionals involved in caring for children with atopic dermatitis. Health care nurses express the same level of corticophobia as parents. The presence of corticophobia among health care professionals may affect parental perspectives and topical corticosteroids adherence negatively.

show abstract

Topical Corticosteroid Phobia in Atopic Dermatitis

2017

View full text Add to dashboard Cite

IMPORTANCE Topical corticosteroid (TCS) phobia refers to the negative feelings and beliefs related to TCSs experienced by patients and patients' caregivers. This phenomenon may be a major contributing factor in treatment failure in patients with atopic dermatitis, yet it has been sparsely described in the literature.OBJECTIVE To systematically assess the nomenclature, prevalence, origins, and effect on treatment adherence of TCS phobia in atopic dermatitis.EVIDENCE REVIEW A literature search was conducted using specific eligibility criteria across electronic databases, including Ovid (MEDLINE, EMBASE), PubMed, and Web of Science, for articles published from January 1, 1946, to October 31, 2016. Included articles must have assessed TCS phobia in patients with atopic dermatitis or their caregivers. Quality ratings of studies were based on a modified version of the Oxford Centre for Evidence-Based Medicine quality rating scheme for individual studies.FINDINGS Of the 490 articles identified by literature search, 16 met the eligibility criteria. All studies were cross-sectional. Topical corticosteroid phobia prevalence ranged from 21.0% (95% CI, 15.8%-26.2%) to 83.7% (95% CI, 81.9%-85.5%). There was significant variation in how phobia was defined, ranging from concern to irrational fear. Questionnaires used to assess for TCS phobia included 1 to 69 questions. In the 2 studies that compared nonadherence between a phobia group and a nonphobia group, patients in both phobia groups were found to have a significantly higher rate of nonadherence (49.4% vs 14.1% and 29.3% vs 9.8%). The sources from which patients were receiving information about corticosteroids included physicians, friends and relatives, broadcast media, print media, and the internet.CONCLUSIONS AND RELEVANCE Features of TCS phobia are commonly reported by patients across cultures and may be associated with a higher rate of nonadherence. Patients with TCS phobia and the sources from which patients are receiving information about corticosteroids may be targetable for intervention to increase adherence to treatment regimens. The nomenclature and assessment methods for TCS phobia used in studies, however, lack standardization, precluding quantitative comparison and extrapolation of data. Additional research, using standardized definitions and methods of assessment, is needed to better characterize this phenomenon and evaluate the efficacy of potential interventions.

show abstract

TOPICOP©: A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents

Cited by 77 publications

References 28 publications

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Topical Corticosteroid Concerns in Dermatological Outpatients: A Cross-Sectional and Interventional Study

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Topical Corticosteroid Phobia in Atopic Dermatitis

Contact Info

Product

Resources

About